Integrated Annual Report

Overview

The report describes Torrent Pharma's transformational acquisition of a controlling stake in J.B. Chemicals & Pharmaceuticals Limited, which expanded its domestic scale and therapeutic reach. The company reported consolidated revenue of ₹13,980 crores for FY 2025-26 and continued to strengthen its international and manufacturing businesses. Sustainability highlights include increased renewable-energy adoption, water recycling, waste diversion and a decarbonisation roadmap. Its community programmes screened more than 20,000 children for malnutrition and anaemia and expanded paediatric healthcare access across underserved regions.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2025-2026
Period: 1 April 2025 – 31 March 2026
Publication date: 22 May 2026
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview